Advertisement

Epitope specific anti-prion antibodies up-regulate apolipoprotein e and disrupt membrane cholesterol homeostasis.

08:29 EDT 22nd May 2013 | BioPortfolio

Summary of "Epitope specific anti-prion antibodies up-regulate apolipoprotein e and disrupt membrane cholesterol homeostasis."

The mechanisms of neuronal degeneration induced by the transformation of normal cellular prion protein (PrP(C)) into disease associated PrP(Sc) are not fully understood. Previous reports have demonstrated that cross-linking cellular prion protein by anti-PrP(C) antibodies can promote neuronal apoptosis.In this report we now show that treatment of neuronal cells with anti-prion antibodies leads to sequestration of free cholesterol in cell membranes, significant over-expression of apolipoprotein E (apoE), and to cytoplasmic phospholipase A2 (cPLA(2)) activation as well as to production of prostaglandin (PGE(2)).These results confirm the in vivo toxic effects and indicate that anti-prion antibody treatment of neurons lead deleterious effects. Finally, great caution should be exerted when adopting antibody-based therapy for prion diseases.

Affiliation

The Royal Veterinary College;

Journal Details

This article was published in the following journal.

Name: The Journal of general virology
ISSN: 1465-2099
Pages:

Links

Medical and Biotech [MESH] Definitions

Epitope Mapping

Methods used for studying the interactions of antibodies with specific regions of protein antigens. Important applications of epitope mapping are found within the area of immunochemistry.

Prpsc Proteins

Abnormal isoform of prion proteins (PRIONS) resulting from a posttranslational modification of the cellular prion protein (PRPC PROTEINS). PrPSc are disease-specific proteins seen in certain human and animal neurodegenerative diseases (PRION DISEASES).

Antibodies, Anti-idiotypic

Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.

Beta 2-glycoprotein I

A 44-kDa highly glycosylated plasma protein that binds phospholipids including CARDIOLIPIN; APOLIPOPROTEIN E RECEPTOR; membrane phospholipids, and other anionic phospholipid-containing moieties. It plays a role in coagulation and apoptotic processes. Formerly known as apolipoprotein H, it is an autoantigen in patients with ANTIPHOSPHOLIPID ANTIBODIES.

Apolipoprotein E4

A major and the second most common isoform of apolipoprotein E. In humans, Apo E4 differs from APOLIPOPROTEIN E3 at only one residue 112 (cysteine is replaced by arginine), and exhibits a lower resistance to denaturation and greater propensity to form folded intermediates. Apo E4 is a risk factor for ALZHEIMER DISEASE and CARDIOVASCULAR DISEASES.

PubMed Articles [ 16326 Associated PubMed Articles listed on BioPortfolio]

Antigenic mimicry-mediated anti-prion effects induced by bacterial enzyme succinylarginine dihydrolase in mice.

Prions, the causative agents of prion diseases, are immunologically tolerated because their major component, prion protein (PrP), is a host-encoded molecule. Therefore, no effective prion vaccines hav...

Progress in the development of therapeutic antibodies targeting prion proteins and beta-amyloid peptides.

Prion diseases and Alzheimer's disease (AD) are characterized by protein misfolding, and can lead to dementia. However, prion diseases are infectious and transmissible, while AD is not. The similariti...

A novel series of anti-human glycophorin A (CD235a) antibodies defining five extra- and intracellular epitopes.

Glycophorin A (GPA, CD235a) is a major membrane glycoprotein and marker of cells of the erythroid lineage. It is also the target of Plasmodium falciparum and of influenza virus. We describe a novel se...

Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness.

The identification and characterization of conserved epitopes on the HIV-1 viral spike that are immunogenic in humans and targeted by neutralizing antibodies is an important step in vaccine design. An...

Alkylating Antitumor Drug Mechlorethamine Conceals A Structured PrP Domain and Inhibits in Vitro Prion Amplification.

Prion diseases are a group of incurable transmissible neurodegenerative disorders. The key molecular event in the pathogenesis of prion diseases is the conversion of the cellular prion protein (PrP(C)...

Clinical Trials [ 2733 Associated Clinical Trials listed on BioPortfolio]

PRION-1: Quinacrine for Human Prion Disease

PRION-1 aims to assess the activity and safety of Quinacrine (Mepacrine hydrochloride) in human prion disease. It also aims to establish an appropriate framework for the clinical assessmen...

Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients

The purpose of this observational research study is to determine when and why patients discontinue, interrupt, or disrupt the regimen of anti-platelet medications prescribed following sten...

Autoimmune Hepatitis Study

The purpose of the study is to determine the role special antibodies play in possibly identifying Autoimmune Hepatitis through the following: Identify the response of specific T cells to...

Safety and Efficacy of Oral Colostrum Derived Anti Influenza Antibodies in Healthy Volunteers

Administration of colostrum enriched with anti-Flu antibodies may alter host's response to the flu virus.

Immune Mechanisms of Rejection in Human Lung Allografts

The investigators have obtained compelling evidence that the development of anti-human leukocyte antigen (anti-HLA) antibodies against mismatched donor antigens significantly correlates wi...

Search BioPortfolio: